Previous 10 | Next 10 |
Highlights First quarter revenue of $846.1 million decreased by 16% as reported with non-respiratory revenue up 5% on a supplemental combined basis (up 7% in constant currency) and respiratory revenue down 72% on a supplemental combined basis Growth in non-respiratory revenue for th...
2023-04-28 12:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-04-22 03:41:17 ET Summary QuidelOrtho presents with attractive business economics. After a strong growth period, the firm is now focused on strategic investments to maintain profitability. If correct, my numbers suggest the firm could attract a substantial re-rating to th...
2023-04-18 21:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-04-15 06:05:00 ET QuidelOrtho (NASDAQ: QDEL) put a collective smile on the faces of its investors at the end of the week. After announcing estimates-beating preliminary results after market hours Thursday, the diagnostics company's share price shot 5% higher the following tradi...
2023-04-13 16:19:55 ET QuidelOrtho ( NASDAQ: QDEL ) forecasts its Q1 revenues to reach $840M to $850M attributable to its Labs segment, with an additional $21M from a resolved collaborative agreement, surpassing the estimated consensus of $744.64M. The forecasted respiratory i...
QuidelOrtho to report first quarter 2023 financial results on May 3, 2023 QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinic...
2023-04-11 08:00:38 ET President Joe Biden has signed legislation to end the U.S. national emergency to respond to the COVID-19 pandemic after bipartisan congressional support, weeks ahead of its expiry alongside a separate public health emergency. The move comes after the Senate cleare...
2023-04-09 06:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-04-06 14:14:11 ET After more than three years, the World Health Organization (WHO) could announce an end to the emergency status of COVID-19 this year, the head of the global body Dr. Tedros Adhanom Ghebreyesus, said Thursday. In early 2020, the WHO named the COVID-19 pandemic a Pu...
News, Short Squeeze, Breakout and More Instantly...
Avantor Set to Join S&P MidCap 400; QuidelOrtho & Schneider National to Join S&P SmallCap 600 Avantor Set to Join S&P MidCap 400; QuidelOrtho & Schneider National to Join S&P SmallCap 600 PR Newswire NEW YORK , July 23, 2024 /PRNewswir...
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it will report its financ...
2024-07-09 04:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...